- Home
- XAIR vs NBY Comparison
XAIR vs NBY Comparison
Compare XAIR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- NBY
- Stock Information
- Founded
- XAIR 2011
- NBY 2000
- Country
- XAIR United States
- NBY United States
- Employees
- XAIR N/A
- NBY N/A
- Industry
- XAIR Medical/Dental Instruments
- NBY
- Sector
- XAIR Health Care
- NBY
- Exchange
- XAIR Nasdaq
- NBY Nasdaq
- Market Cap
- XAIR 17.0M
- NBY 15.7M
- IPO Year
- XAIR N/A
- NBY 2007
- Fundamental
- Price
- XAIR $2.40
- NBY $2.14
- Analyst Decision
- XAIR Strong Buy
- NBY Strong Buy
- Analyst Count
- XAIR 1
- NBY 1
- Target Price
- XAIR $11.00
- NBY $0.85
- AVG Volume (30 Days)
- XAIR 8.8M
- NBY 21.4M
- Earning Date
- XAIR 11-10-2025
- NBY 11-06-2025
- Dividend Yield
- XAIR N/A
- NBY N/A
- EPS Growth
- XAIR N/A
- NBY N/A
- EPS
- XAIR N/A
- NBY 0.41
- Revenue
- XAIR $4,782,000.00
- NBY $9,781,000.00
- Revenue This Year
- XAIR $265.24
- NBY $23.91
- Revenue Next Year
- XAIR $136.17
- NBY $32.05
- P/E Ratio
- XAIR N/A
- NBY $8.11
- Revenue Growth
- XAIR 168.20
- NBY 113.47
- 52 Week Low
- XAIR $2.02
- NBY $0.46
- 52 Week High
- XAIR $13.52
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- XAIR 48.22
- NBY 52.56
- Support Level
- XAIR $2.13
- NBY $2.28
- Resistance Level
- XAIR $4.78
- NBY $3.30
- Average True Range (ATR)
- XAIR 0.33
- NBY 0.64
- MACD
- XAIR 0.05
- NBY -0.04
- Stochastic Oscillator
- XAIR 11.63
- NBY 23.44
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.